Merova Healthcare Holding
05Merova Care Solutions

Regional commercialization for differentiated healthcare products.

Marketing, registering, and sublicensing differentiated healthcare products across the GCC, MENA, and India.

5.1Capabilities

Market access as a system, not a service.

Care Solutions is purpose-built for differentiated MedTech entering complex regulatory environments — closing the gap between approval and commercial scale.

01

Registration

UAE MoH pathway plus regional licensing across GCC, MENA, and India.

02

Marketing

Hospital, specialist, and provider channel deployment with KOL engagement.

03

Sublicensing

Regional rights structuring for partner distribution beyond core markets.

04

Reimbursement

Payer engagement and value-dossier development for new technologies.

5.2Regional Footprint

GCC

UAE · Saudi Arabia · Qatar · Kuwait · Oman · Bahrain

MENA

Egypt · Jordan · Morocco · adjacent emerging markets

India

Tier-1 metros — sublicensing or direct deployment

5.3Pipeline Under Commercialization

  • Drug-Device Combination

    BioQ Pharma

    Proprietary invenious™ infusion platform. Four approved products with 44 global marketing authorizations and 50+ US patents across pain, anesthesia and oncology.

  • AI-Enabled Diagnostics

    Periwinkle Technologies

    Smart Scope® CX detects cervical cancer in under five minutes, offline-capable. Pre-IPO. Pipeline includes oral and breast cancer screening.

  • Neurotechnology

    Exsurgo 2.0

    Axon — a clinically validated BCI headset for chronic pain. 30-minute at-home sessions with remote monitoring. Hardware plus subscription model.

  • AI Cardiovascular Diagnostics

    CorVista

    First non-invasive point-of-care cardiovascular test. AI cloud results in ~30 minutes. No radiation, no capital equipment, per-scan billing.

  • Therapeutic Devices

    Revian

    FDA-cleared LED hair regrowth platform. 65+ patents and ~75% gross margins. Channels across physicians, affiliates and DTC.

  • Cancer Diagnostics

    Vigilant Biosciences

    OraFusion — chairside oral cancer risk assessment combining saliva biomarkers, clinical factors and AI. Recurring consumables business model.

  • Neurotechnology · Devices

    Vermillion Health

    Non-invasive EEG-based chronic pain treatment. Hardware plus SaaS subscription, addressing a large global market without drugs.

  • Diagnostics

    Capnia

    Non-invasive neonatal jaundice diagnostic device. Quick and endorsed by the APA. Large addressable market in GCC, MENA and India.

Partner with Care SolutionsView portfolio →